Search
for
Sort by
Research 61–90 of 353
- A Gender Hypothesis of sex disparities in adverse drug events
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations
- Alopecia associated with quetiapine
- Physicochemical Characterization of Chitosan-Decorated Finasteride Solid Lipid Nanoparticles for Skin Drug Delivery
- Blockbuster Weight-Loss Drugs Not Tied to Suicidality, Studies Show
- Squarticles as the nanoantidotes to sequester the overdosed antidepressant for detoxification
- Effects of local and systemic medications on eye health: Adverse reactions
- Nail Hyperpigmentation Following Valproic Acid Use: A Rare Case Report
- Trichotillomania and Traction Alopecia
- The Impact of Metformin on Plasma Prolactin Levels in Antipsychotics‐Treated Men With Hyperprolactinemia and Early‐Onset Androgenic Alopecia
- Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutasteride with Ketoconazole
- Advancements in Drug Repurposing: Examples in Psychiatric Medications
- Chemistry, Pharmacology and Therapeutic Potential of Decursin: A Promising Natural Lead for New Drug Discovery and Development
- Integrated edge information and pathway topology for drug-disease associations
- Adverse Cutaneous Reactions to Antidepressants
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- Childhood onset trichotillomania: a retrospective analysis of 78 cases visiting tertiary general hospital
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
- Medicinal Chemistry of Drugs with <i>N</i>-Oxide Functionalities
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Hair cortisol in drug-naïve first-episode individuals with psychosis
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Cancer prevalence after exposure to Wnt-activating drugs: a systematic review
- The role of biotransformation processes in mediating interactions between psychotropic drugs and natural products
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database